Inhibitory effect of somatostatin on the aldosterone response to angiotensin II: in vitro studies

  • M. Boscaro
  • C. Scaroni
  • C. R. W. Edwards
  • F. Mantero
Short Communication


It has been demonstrated that somatostatin (SRIF) can suppress hypophyseal and extrahypophyseal hormones; moreover, many studies have shown that SRIF inhibits frusemide-induced hyperreninemia in normal man, and renin and aldosterone in renovascular hypertension, possibly through a beta-adrenergic block. To further investigate the possible aldosterone-inhibiting effect of somatostatin, we have carried out in vitro studies using isolated perfused rat zona glomerulosa cells suspended in Biogel. Paired columns were set up and the cells stimulated using either angiotensin II, ACTH, serotonin or potassium. One column was perfused with somatostatin (3–4 ng/ml) and the other was used as a control. Aldosterone was measured by highly specific direct radioimmunoassay. Somatostatin significantly blocked the aldosterone response to angiotensin II but not to ACTH, serotonin or potassium. The inhibitory effect of somatostatin persisted as long as it was added to the medium; the aldosterone response to angiotensin II was progressively restored after discontinuation of the SRIF infusion. From these data it might be suggested that the inhibitory effect of somatostatin on aldosterone production is not cAMP-dependent, since ACTH maintains its stimulatory capacity. The recent demonstration of the presence of specific somatostatin receptors on the rat adrenal cells suggests that its inhibitory effect could be mediated by the second messenger system rather than the interaction with angiotensin II receptors.


Somatostatin angiotensin II ACTH serotonin potassium aldosterone secretion 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Fujimoto M.Y., Ensinck J.W., Williams R.H. Somatostatin inhibits insulin and glucagon release by monolayer cell culture of rat endocrine pancreas. Life Sci. 15: 1999, 1974.PubMedCrossRefGoogle Scholar
  2. 2.
    Ward F.R., Lebrance K., Yen S.S.C. The inhibitory effect of somatostatin on growth hormone, insulin and glucagon secretion in diabetes mellitus. J. Clin. Endocrinol. Metab. 41:527, 1975.PubMedCrossRefGoogle Scholar
  3. 3.
    Bloom S.R., Mortimer G.H., Thorner M.O., Besser G.M., Hall R., Gomez-Pan A., Roy V.M., Russel R.C.G., Goy D.H., Kastin A.J., Shally A.V. Inhibition of gastrin and gastric acid secretion by growth-hormone release-inhibiting hormone. Lancet 2:1106, 1974.PubMedCrossRefGoogle Scholar
  4. 4.
    Rosenthal J., Raptis S., Escobar-Jimenez F., Pfeiffer E.F. Inhibition of frusemide-induced hyperreninemia by growth-hormone release inhibiting hormone in man. Lancet 1:772, 1978.Google Scholar
  5. 5.
    Arlart I., Rosenthal J., Pal S., Raptis S. Einfluss von somatostatin auf renin, aldosteron und blutdruck bei unilateral renovaskulärer hypertonic Verh. Dtsch. Ges. Inn. Med. 84:824, 1978.Google Scholar
  6. 6.
    Rosenthal J., Escobar-Jimenez F., Raptis S. Prevention by somatostatin of rise in blood pressure and plasma renin mediated by beta-receptor stimulation. Clin. Endocrinol. (Oxf.) 6:455, 1977.CrossRefGoogle Scholar
  7. 7.
    Diel F., Holz J., Bethge N. Failure of somatostatin and beta-endorphin to affect bovine adrenal cortex cells in vitro. Horm. Metab. Res. 13:95, 1981.PubMedCrossRefGoogle Scholar
  8. 8.
    Aguilera G., Harwood J., Catt K. Somatostatin modulates the effects of angiotensin II (All) in the adrenal glomerulosa zone. Clin. Res. 29:564A, 1981.Google Scholar
  9. 9.
    Lowry P.J., McMartin C. Measurement of stimulation and inhibition of steroidogenesis in isolated rat adrenal cells by using column perfusion. Biochem. J. 142:287, 1974.PubMedCentralPubMedGoogle Scholar
  10. 10.
    Al-Dujaili E.A.S., Edwards C.R.W. The development and application of direct radioimmunoassay for plasma aldosterone using 125I-labelled ligand — comparison of three methods. J. Clin. Endocrinol. Metab. 46:105, 1978.PubMedCrossRefGoogle Scholar
  11. 11.
    Fujita K., Aguilera G., Catt K.J. The role of cyclic AMP in aldosterone production by isolated zona glomerulosa cells. J. Biol. Chem. 254:8567, 1976.Google Scholar
  12. 12.
    Shima S., Kawashima Y., Harai M. Studies on cyclic nucleotides in the adrenal gland VIII: Effects of angiotensin on adenosine 3′-5′ monophosphate and steroidogenesis in the adrenal cortex. Endocrinology 103:1361, 1978.PubMedCrossRefGoogle Scholar
  13. 13.
    Fakunding J.L., Catt K.J. Dependence of aldosterone stimulation in adrenal glomerulosa cells on calcium uptake: effects of lanthanum and verapamil. Endocrinology 107:1345, 1980.PubMedCrossRefGoogle Scholar
  14. 14.
    Douglas W.W., Kanno T., Sampson S.R. Effects of acetylcholine and other medullary secreta-gogues and antagonists on the membrane potencial of adrenal chromaffin cells: an analysis, employing techniques of tissue culture. J. Phisiol. (Lond.) 188:107, 1967.Google Scholar
  15. 15.
    Douglas W.W. Involvement of calcium in exocytosis and the exocytosis-vesciculation sequence. Biochem. Soc. Symp. 39:I, 1974.Google Scholar
  16. 16.
    Basabe J.C., Cresto J.C., Aparicio N. Studies on the mode of action of somatostatin on insulin secretion. Endocrinology 101:1436, 1977.PubMedCrossRefGoogle Scholar
  17. 17.
    Edwards C.R.W., Al-Dujaili E.A.S., Boscaro M., Quyyumi S., Miall P.A., Rees L.H. In vivo and in vitro studies on the effect of metoclopra-mide on aldosterone secretion. Clin. Endocrinol. (Oxf.) 13:45, 1980.CrossRefGoogle Scholar
  18. 18.
    McKenna T.J., Island D.P., Nicholson W.E., Liddle G.W. Stimulation of aldosterone production by catecholamines in vitro. “Sixth International Congress of Endocrinology” Melbourne 1980. Abstracts 395, 1980, p. 407.Google Scholar
  19. 19.
    Edwards C.R.W., Miall P.A., Hanker J.P., Thorner M.O., Al-Dujaili E.A.S., Besser G.M. Inhibition of the plasma aldosterone response to frusemide by bromocriptine. Lancet 2:903, 1975.PubMedCrossRefGoogle Scholar
  20. 20.
    Boscaro M., Al-Dujaili E.A.S., Edwards C.R.W. In vitro studies on the mechanism of inhibition by bromocriptine, lisuride and metergoline of angiotensin II induced aldosterone release. “XII Acta Endocrinologica Congress” (Kbh.) Munich 1979. Abstracts 342, 1979, p. 342. Suppl. 225.Google Scholar
  21. 21.
    Aguilera G., Harwood J.P., Catt, K.J. Somatostatin modulates effects of angiotensin II in adrenal glomerulosa zone. Nature 292:262, 1981.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1982

Authors and Affiliations

  • M. Boscaro
    • 1
  • C. Scaroni
    • 1
  • C. R. W. Edwards
    • 2
  • F. Mantero
    • 1
  1. 1.Istituto di Semeiotica MedicaUniversità di PadovaPadovaItaly
  2. 2.Department of EndocrinologySt. Bartholomew’s HospitalLondonUK

Personalised recommendations